School of Medicine
Showing 1-100 of 125 Results
-
Arash Alavi
Software Engineering Director, Genetics
Current Role at StanfordSoftware Researcher and Engineer
-
Amir Bahmani
Stanford Lecturer and Director of Deep Data Research Center (DDRC), Genetics
BioAmir Bahmani is a Lecturer and Director of Stanford's Deep Data Research Center (https://deepdata.stanford.edu), the Research and Development Lead at Stanford Center for Genomics and Personalized Medicine (SCGPM) at Stanford School Medicine. He has been working on distributed and parallel computing applications since 2008. Currently, Amir is an active researcher in the VA Million Veteran Program (MVP), Human Tumor Atlas Network (HTAN), the Human BioMolecular Atlas Program (HuBMAP), Stanford Metabolic Health Center (MHC) and Integrated Personal Omics Profiling (iPOP).
-
Yanan Feng
Sr. Research Scientist - Basic Life, Genetics
Current Role at StanfordSenior Research Scientist, Department of Genetics, Dr. Stanley N. Cohen's lab
-
Fereshteh Jahanbani
Basic Life Research Scientist, Genetics
BioDr. Jahanbani received her PharmD from Tehran University of Medical Sciences (TUMS) and PhD in pharmacology from Iran University of Medical Sciences (IUMS) and her postdoctoral degree from Case Western Reserve University (CWRU) and University of California, Santa Cruz (UCSC). She joined Stanford Center for Genomics and Personalized Medicine in June 2012. Her work is focused on better understanding the etiology of chronic complex conditions and multi-morbidity using multi-omics and precision health approaches. She has been leading ME/CFS related disorders multi-omics study combining the power of both family and population approaches and also cofounded “Research To The People at Stanford Program”.
-
Peter William Earl Kane
Director, Research to the People, Genetics
BioPeter is the Director of Research to the People @ Stanford (https://rttp.stanford.edu).
Rare Disease: Currently organizing a collaborative study for Hypophosphatasia, a rare metabolic bone disease. Please contact us if you would like to be involved!
Oncology: Research to the People at Stanford is a program for patients who have exhausted their clinical options and need to move beyond standard of care. We generate deep sequencing and multi-omics data, create cell-lines, and host tumor boards to interrogate new therapeutic possibilities.
Our vision is to produce 100 of the deepest cancer case studies possible.
Research to the People joined Dr. Michael Snyder's Lab at Stanford Medicine in July 2021. -
Xin Liu
Basic Life Science Research Scientist, Genetics
BioXin Liu is a postdoctoral Research Scientist in the Department of Genetics at Stanford University. Xin holds a PhD in Chemistry from the University of Michigan, Ann Arbor. Her basic research interests include RNA and protein biochemistry, enzymology, cancer immunology, and autoimmune disease. She has published papers in several prestigious journals in the field of biochemistry, including Nature Communications, Journal of American Chemical Society, and Nucleic Acids Research. The highlight of her multidisciplinary research includes the development of high-throughput enzymatic methods to discover anti-microbial agents and to reveal mechanisms behind human mitochondrial diseases, as well as innovative applications of genome engineering and machine-learning to decode principles of RNA editing in human cells. Her current research focuses on the mechanistic study of innate immune pathways.
-
Ramesh Nair
Director of Bioinformatics, SCGPM, Genetics
Current Role at StanfordDirector, Bioinformatics
Stanford Center for Genomics and Personalized Medicine (SCGPM)
Center of Excellence in Stem Cell Genomics (CESCG)
Stanford University School of Medicine -
Antonio Ray Rios
Stanford Student Employee, Genetics
BioUndergraduate student majoring in bioengineering while serving as a research assistant in the Stanley Qi Lab, pioneer of CRISPRa/i technologies.
-
Morteza Roodgar DVM, PhD
Veterinarian Research Scientist, Genetics
BioDr. Morteza Roodgar is a veterinarian scientist with a research focus on Primate induced Pluripotent Stem Cells (iPSCs) and long-read genomics tools.
Dr. Roodgar's research focus is on primate stem cell biology, immunology, and comparative genomics of nonhuman primate models for human diseases. The long-term goal of Dr. Roodgar's research is to Replace, Reduce and Refine (aka 3 R’s) the use of animals in biomedical research leveraging primate induced pluripotent stem cells (iPSCs) and long-read genomic tools to speed up preclinical testing.
Previous research includes immunology and genomic susceptibility to infectious diseases (e.g., tuberculosis, TB) in nonhuman primate models, Preventive Veterinary Medicine and emerging zoonotic diseases (e.g., COVID-19 and Monkeypox).